However, the observation that the stroke hazard appeared to double for ischemic and hemorrhagic strokes considered separately suggests that, in addition to prothrombotic effects, erythropoiesis-stimulating agents are causing stroke through additional mechanisms, of which the 2 mmHg higher DBP in the higher Hb target group remains the most plausible (105). This evidence concerns the gene GSTM1 and Stroke.